A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 for 12 Weeks in the Treatment of Moderate-to- Severe Acne Vulgaris (Study FX2017-22)
If you have moderate to severe acne, we invite you to join our investigational drug study of a topical treatment foam. Eligible participants may received compensation and study drugs and related care at no cost.
| Clinical Study Identifier | TX15590 |
|---|---|
| Sponsor | Foamix Pharmaceutic |
| Last Modified on | 7 November 2020 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.